Abstract
Human endogenous retroviruses (HERVs) have been proposed as etiological cofactors in chronic diseases such as cancer, autoimmunity and neurological disease. HERV RNA expression is also increased in several autoimmune diseases and cancers. However, only a few studies have analyzed the expression levels of HERV-derived proteins in normal and diseased tissues. Here, we investigated the expression profiles of HERV-K Env protein, which is the most well-known pathogen, from normal and cancer tissue microarray. Normal and cancer tissue microarray slides containing 59 normal or 60 tumor surgical specimens, respectively were immunostained with mouse monoclonal antibody to HERV-K and staining intensity was scored. The expression of HERV-K Env protein is generally low in normal tissues but high in specific tissues including bronchus submucosal gland, salivary gland acini, pancreas acini, testis seminiferous tubule, uterine cervix epithelium, ovary stroma, skin epidermis, and heart. The expression of HERV-K Env protein in tumors was usually higher than normal tissues and specifically high in breast, liver, stomach, prostate, and ovarian cancer. This study provides protein expression profiles of HERV-K Env protein in human normal and cancer tissues and provides a good reference for further studies on the expression patterns and roles of HERV-K Env protein in normal organs and various cancers. Further studies with specific organs or cancers and a statistically significant numbers of samples are necessary.
Similar content being viewed by others
References
Agoni L, Guha C, Lenz J (2013) Detection of human endogenous retrovirus K (HERV-K) transcripts in human prostate cancer cell lines. Front Oncol 3:180
Bannert N, Kurth R (2004) Retroelements and the human genome: new perspectives on an old relation. Proc Natl Acad Sci USA 101(Suppl 2):14572–14579
Belshaw R, Pereira V, Katzourakis A, Talbot G, Paces J, Burt A, Tristem M (2004) Long-term reinfection of the human genome by endogenous retroviruses. Proc Natl Acad Sci USA 101:4894–4899
Belshaw R, Dawson AL, Woolven-Allen J, Redding J, Burt A, Tristem M (2005) Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): implications for present-day activity. J Virol 79:12507–12514
Bhardwaj N, Montesion M, Roy F, Coffin JM (2015) Differential expression of HERV-K (HML-2) proviruses in cells and virions of the teratocarcinoma cell line Tera-1. Viruses 7:939–968
Blond JL, Lavillette D, Cheynet V, Bouton O, Oriol G, Chapel-Fernandes S, Mandrand B, Mallet F, Cosset FL (2000) An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J Virol 74:3321–3329
Brodsky I, Foley B, Gillespie D (1993) Expression of human endogenous retrovirus (HERV-K) in chronic myeloid leukemia. Leuk Lymphoma 11(Suppl 1):119–123
Buscher K, Trefzer U, Hofmann M, Sterry W, Kurth R, Denner J (2005) Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Res 65:4172–4180
Conley AB, Piriyapongsa J, Jordan IK (2008) Retroviral promoters in the human genome. Bioinformatics 24:1563–1567
Contreras-Galindo R, Kaplan MH, Leissner P, Verjat T, Ferlenghi I, Bagnoli F, Giusti F, Dosik MH, Hayes DF, Gitlin SD et al (2008) Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer. J Virol 82:9329–9336
Florl AR, Lower R, Schmitz-Drager BJ, Schulz WA (1999) DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br J Cancer 80:1312–1321
Freimanis G, Hooley P, Ejtehadi HD, Ali HA, Veitch A, Rylance PB, Alawi A, Axford J, Nevill A, Murray PG et al (2010) A role for human endogenous retrovirus-K (HML-2) in rheumatoid arthritis: investigating mechanisms of pathogenesis. Clin Exp Immunol 160:340–347
Fuchs NV, Loewer S, Daley GQ, Izsvak Z, Lower J, Lower R (2013) Human endogenous retrovirus K (HML-2) RNA and protein expression is a marker for human embryonic and induced pluripotent stem cells. Retrovirology 10:115
Gupta R, Michaud HA, Zeng X, Debbaneh M, Arron ST, Jones RB, Ormsby CE, Nixon DF, Liao W (2014) Diminished humoral responses against and reduced gene expression levels of human endogenous retrovirus-K (HERV-K) in psoriasis. J Transl Med 12:256
Hahn S, Ugurel S, Hanschmann KM, Strobel H, Tondera C, Schadendorf D, Lower J, Lower R (2008) Serological response to human endogenous retrovirus K in melanoma patients correlates with survival probability. AIDS Res Hum Retrovir 24:717–723
Herbst H, Sauter M, Mueller-Lantzsch N (1996) Expression of human endogenous retrovirus K elements in germ cell and trophoblastic tumors. Am J Pathol 149:1727–1735
Jeong BH, Lee YJ, Carp RI, Kim YS (2010) The prevalence of human endogenous retroviruses in cerebrospinal fluids from patients with sporadic Creutzfeldt–Jakob disease. J Clin Virol 47:136–142
Kaufmann S, Sauter M, Schmitt M, Baumert B, Best B, Boese A, Roemer K, Mueller-Lantzsch N (2010) Human endogenous retrovirus protein Rec interacts with the testicular zinc-finger protein and androgen receptor. J Gen Virol 91:1494–1502
Kessler AF, Wiesner M, Denner J, Kammerer U, Vince GH, Linsenmann T, Lohr M, Ernestus RI, Hagemann C (2014) Expression-analysis of the human endogenous retrovirus HERV-K in human astrocytic tumors. BMC Res Notes 7:159
Krone B, Grange JM (2010) Melanoma, Darwinian medicine and the inner world. J Cancer Res Clin Oncol 136:1787–1794
Kurth R, Bannert N (2010) Beneficial and detrimental effects of human endogenous retroviruses. Int J Cancer 126:306–314
Manghera M, Ferguson J, Douville R (2014) Endogenous retrovirus-K and nervous system diseases. Curr Neurol Neurosci Rep 14:488
Mi S, Lee X, Li X, Veldman GM, Finnerty H, Racie L, LaVallie E, Tang XY, Edouard P, Howes S et al (2000) Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403:785–789
Oja M, Peltonen J, Blomberg J, Kaski S (2007) Methods for estimating human endogenous retrovirus activities from EST databases. BMC Bioinformatics 8(Suppl 2):S11
Perot P, Mugnier N, Montgiraud C, Gimenez J, Jaillard M, Bonnaud B, Mallet F (2012) Microarray-based sketches of the HERV transcriptome landscape. PLoS ONE 7:e40194
Rhyu DW, Kang YJ, Ock MS, Eo JW, Choi YH, Kim WJ, Leem SH, Yi JM, Kim HS, Cha HJ (2014) Expression of human endogenous retrovirus env genes in the blood of breast cancer patients. Int J Mol Sci 15:9173–9183
Romanish MT, Cohen CJ, Mager DL (2010) Potential mechanisms of endogenous retroviral-mediated genomic instability in human cancer. Semin Cancer Biol 20:246–253
Rycaj K, Plummer JB, Yin B, Li M, Garza J, Radvanyi L, Ramondetta LM, Lin K, Johanning GL, Tang DG et al (2015) Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells. Clin Cancer Res 21:471–483
Sacha JB, Kim IJ, Chen L, Ullah JH, Goodwin DA, Simmons HA, Schenkman DI, von Pelchrzim F, Gifford RJ, Nimityongskul FA et al (2012) Vaccination with cancer- and HIV infection-associated endogenous retrotransposable elements is safe and immunogenic. J Immunol 189:1467–1479
Simpson GR, Patience C, Lower R, Tonjes RR, Moore HD, Weiss RA, Boyd MT (1996) Endogenous D-type (HERV-K) related sequences are packaged into retroviral particles in the placenta and possess open reading frames for reverse transcriptase. Virology 222:451–456
Wallace TA, Downey RF, Seufert CJ, Schetter A, Dorsey TH, Johnson CA, Goldman R, Loffredo CA, Yan P, Sullivan FJ et al (2014) Elevated HERV-K mRNA expression in PBMC is associated with a prostate cancer diagnosis particularly in older men and smokers. Carcinogenesis 35:2074–2083
Acknowledgments
This research was supported by High-Tech Convergence Technology Development Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT& Future Planning (2014M3C1A3051981) and a grant from the Kosin University College of Medicine (2014).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Jo, JO., Kang, YJ., Ock, M.S. et al. Expression profiles of HERV-K Env protein in normal and cancerous tissues. Genes Genom 38, 91–107 (2016). https://doi.org/10.1007/s13258-015-0343-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13258-015-0343-9